Anatara Lifesciences announced the formation of its Product Development Advisory Board. The Advisory Board consists of five key external experts: Dr. Rebecca Burgell, Dr. Jakob Begun, Prof Barry Campbell, Assoc Prof Simon Keely and Prof Peter Gibson, who will serve as the Chairman. The newly appointed Advisory Board will work closely with the Anatara Board and management team as it continues to advance its human gastrointestinal (GI) health program, in the burgeoning gut health market. The Advisory Board will provide advice on issues relating to Anatara's research priorities and strategies, and the Company's product development programs. Professor Peter Gibson will assume the role of Chairman and has more than 30 years' experience in gastrointestinal health. Peter Gibson is the Director of Gastroenterology at The Alfred and Monash University, Dr. Rebecca Burgell is a consultant gastroenterologist with an interest in inflammatory bowel disease, clinical nutrition, pelvic floor dysfunction and functional gastrointestinal disorders. She is the Head of the Functional Gastrointestinal disorders service and medical lead of the home enteral nutrition program at Alfred Health. . Jakob Begun obtained his MD and PhD in genetics at Harvard Medical School. He serves on the steering committees of the Australia and New Zealand IBD Consortium and the Australian IBD Association. Dr. Keely is chief investigator of the Hunter Medical Research Institute Gastrointestinal Research Group.